These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36832265)

  • 1. Diagnostic and Prognostic Roles of C-Reactive Protein, Procalcitonin, and Presepsin in Acute Kidney Injury Patients Initiating Continuous Renal Replacement Therapy.
    Han S; Kim MJ; Ko HJ; Lee EJ; Kim HR; Jeon JW; Ham YR; Na KR; Lee KW; Lee SI; Choi DE; Park H
    Diagnostics (Basel); 2023 Feb; 13(4):. PubMed ID: 36832265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic value of presepsin and procalcitonin in non-infectious organ failure, sepsis, and septic shock: a prospective observational study according to the Sepsis-3 definitions.
    Lee S; Song J; Park DW; Seok H; Ahn S; Kim J; Park J; Cho HJ; Moon S
    BMC Infect Dis; 2022 Jan; 22(1):8. PubMed ID: 34983420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between presepsin, procalcitonin, and CRP as biomarkers to diagnose sepsis in critically ill patients.
    Juneja D; Jain N; Singh O; Goel A; Arora S
    J Anaesthesiol Clin Pharmacol; 2023; 39(3):458-462. PubMed ID: 38025554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of accuracy of presepsin and procalcitonin concentrations in diagnosing sepsis in patients with and without acute kidney injury.
    Nakamura Y; Hoshino K; Kiyomi F; Kawano Y; Mizunuma M; Tanaka J; Nishida T; Ishikura H
    Clin Chim Acta; 2019 Mar; 490():200-206. PubMed ID: 30201367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combination of procalcitonin and C-reactive protein or presepsin alone improves the accuracy of diagnosis of neonatal sepsis: a meta-analysis and systematic review.
    Ruan L; Chen GY; Liu Z; Zhao Y; Xu GY; Li SF; Li CN; Chen LS; Tao Z
    Crit Care; 2018 Nov; 22(1):316. PubMed ID: 30463590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma presepsin for mortality prediction in patients with sepsis-associated acute kidney injury requiring continuous kidney replacement therapy.
    Lee GB; Lee JW; Yoon SH; Hwang WM; Yun SR; Koh DH; Park Y
    Kidney Res Clin Pract; 2024 Jul; 43(4):457-468. PubMed ID: 38934036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment.
    Behnes M; Bertsch T; Lepiorz D; Lang S; Trinkmann F; Brueckmann M; Borggrefe M; Hoffmann U
    Crit Care; 2014 Sep; 18(5):507. PubMed ID: 25190134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presepsin versus other biomarkers to predict sepsis and septic shock in patients with infection defined by Sepsis-3 criteria: the PREDI study of diagnostic accuracy.
    Contenti J; Occelli C; Lemoel F; Ferrari P; Levraut J
    Emergencias; 2019 Oct; 31(5):311-317. PubMed ID: 31625302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Utility of Procalcitonin, Presepsin, and the VACO Index for Predicting 30-day Mortality in Hospitalized COVID-19 Patients.
    Park M; Hur M; Kim H; Lee CH; Lee JH; Kim HW; Nam M
    Ann Lab Med; 2022 Jul; 42(4):406-414. PubMed ID: 35177561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Continuous renal replacement therapy and negative fluid balance improves renal function and prognosis of patients with acute kidney injury in sepsis].
    Sun Z; Sun F; Niu C; Shen X; Ye H; Cao H
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 May; 27(5):321-6. PubMed ID: 26003633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin and N-Terminal Pro-B-Type Natriuretic Peptide for Prognosis in Septic Acute Kidney Injury Patients Receiving Renal Replacement Therapy.
    Sheng X; Yang J; Yu G; Fei Y; Bao H; Yin J; Huang W; Tian Z; Wang N; Ronco C
    Blood Purif; 2019; 48(3):262-271. PubMed ID: 31311006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of plasma presepsin levels in determining the incidence of septic shock and mortality in patients with sepsis.
    Kahveci U; Ozkan S; Melekoglu A; Usul E; Ozturk G; Cetin E; Abatay K; Sahin A
    J Infect Dev Ctries; 2021 Jan; 15(1):123-130. PubMed ID: 33571154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of biomarkers in screening for neonatal sepsis - A single center -hospital based study.
    Rashwan NI; Hassan MH; Mohey El-Deen ZM; Ahmed AE
    Pediatr Neonatol; 2019 Apr; 60(2):149-155. PubMed ID: 29895470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presepsin and prognostic nutritional index are predictors of septic acute kidney injury, renal replacement therapy initiation in sepsis patients, and prognosis in septic acute kidney injury patients: a pilot study.
    Shimoyama Y; Umegaki O; Kadono N; Minami T
    BMC Nephrol; 2021 Jun; 22(1):219. PubMed ID: 34118899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of presepsin in the diagnosis of sepsis in patients with or without acute kidney injury.
    Nakamura Y; Ishikura H; Nishida T; Kawano Y; Yuge R; Ichiki R; Murai A
    BMC Anesthesiol; 2014; 14():88. PubMed ID: 25309126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presepsin and procalcitonin as biomarkers of systemic bacterial infection in patients with rheumatoid arthritis.
    Tsujimoto K; Hata A; Fujita M; Hatachi S; Yagita M
    Int J Rheum Dis; 2018 Jul; 21(7):1406-1413. PubMed ID: 27291096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between continuous renal replacement therapy as treatment for sepsis-associated acute kidney injury and trend of lactate trajectory as risk factor of 28-day mortality in intensive care units.
    Wang Z; Zhang L; Xu F; Han D; Lyu J
    BMC Emerg Med; 2022 Feb; 22(1):32. PubMed ID: 35227200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presepsin vs Procalcitonin as Predictors of Sepsis Outcome.
    Narendra S; Wyawahare M; Adole PS
    J Assoc Physicians India; 2022 Nov; 70(11):11-12. PubMed ID: 37355942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procalcitonin decrease predicts survival and recovery from dialysis at 28 days in patients with sepsis-induced acute kidney injury receiving continuous renal replacement therapy.
    Kim IY; Kim S; Ye BM; Kim MJ; Kim SR; Lee DW; Lee SB
    PLoS One; 2022; 17(12):e0279561. PubMed ID: 36574383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Could presepsin be an alternative marker in the early diagnosis of sepsis in COVID-19?
    Güleç RD; Arslan FD; Çalışkan T; Şenoǧlu N; Yılmaz N; Atalay S; Pirim İ
    Scand J Clin Lab Invest; 2022 Apr; 82(2):108-114. PubMed ID: 35103516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.